Nearly 1.9 lakh cancer cases in India linked to viral, bacterial infections, says Lancet study
Source Entity
Anuradha Mascarenhas
A 2024 Lancet Oncology study reveals that 1.9 lakh cancer cases in India are linked to viral and bacterial infections. Primary drivers include HPV, Hepatitis B and C, and H. Pylori, highlighting the critical role of vaccination and early intervention in cancer prevention.
The Silent Burden: Analyzing Infection-Linked Cancers in India
A landmark 2024 study published in The Lancet Oncology has brought a critical public health issue to the forefront: the significant correlation between infectious agents and cancer incidence in India. With approximately 1.9 lakh cancer cases linked to viral and bacterial pathogens, the report underscores a preventable dimension of the oncology crisis. Globally, this phenomenon accounts for 12% of all new cancer diagnoses, totaling 2.3 million cases, positioning infection control as a vital pillar of global cancer strategy.
HPV and the Cervical Cancer Crisis
Central to these findings is the role of the Human Papillomavirus (HPV), which accounts for the largest portion of these infection-attributable cases in India—surpassing one lakh instances. HPV is the primary driver of cervical cancer, a condition that remains a leading cause of mortality among Indian women. The study reinforces the urgent necessity of widespread HPV vaccination programs, which serve as a primary preventative measure to interrupt the transmission cycle and significantly reduce the long-term burden on the healthcare system.
Hepatitis and Liver Malignancy
Beyond HPV, the study highlights the heavy toll of chronic Hepatitis B and Hepatitis C infections. These pathogens are established precursors to hepatocellular carcinoma (HCC), a common and aggressive form of liver cancer. The persistence of these viruses in the population indicates a need for enhanced screening and early treatment protocols. Addressing these chronic infections is not merely a matter of managing liver disease, but a direct intervention strategy to curb the rising incidence of liver-related malignancies.
The Role of Bacterial Pathogens
While viral agents often dominate the conversation, the role of bacteria is equally significant. The study identifies Helicobacter pylori (H. Pylori) as a major contributor, accounting for 47,000 cases, primarily gastric cancers. Additionally, the Epstein-Barr virus is linked to 22,000 cases. These figures illustrate the diverse biological landscape of oncogenesis in India, where common infections, if left untreated, can evolve into life-threatening conditions over time.
Implications for Public Health Policy
This data serves as a clarion call for policy shifts. By focusing on infectious disease control—through vaccination, antibiotic stewardship, and routine health screenings—India can effectively 'prevent' a substantial portion of its cancer burden before it manifests. The transition from reactive oncology treatment to proactive, infection-focused prevention represents the most sustainable path forward for the national health infrastructure.
Future Trends and Conclusion
As we look toward the future, the integration of infectious disease management into cancer care will be paramount. If vaccination rates increase and early detection of chronic infections becomes a standard practice, we may see a significant decline in these specific cancer categories. The Lancet study serves as an essential baseline for tracking the success of these public health initiatives and highlights that, for many, the fight against cancer begins long before the first tumor is detected.